Literature DB >> 26334258

Addition of Histology to the Paris Classification of Pediatric Crohn Disease Alters Classification of Disease Location.

Melissa A Fernandes1, Sofia G Verstraete, Elizabeth A Garnett, Melvin B Heyman.   

Abstract

OBJECTIVES: The aim of the study was to investigate the value of microscopic findings in the classification of pediatric Crohn disease (CD) by determining whether classification of disease changes significantly with inclusion of histologic findings.
METHODS: Sixty patients were randomly selected from a cohort of patients studied at the Pediatric Inflammatory Bowel Disease Clinic at the University of California, San Francisco Benioff Children's Hospital. Two physicians independently reviewed the electronic health records of the included patients to determine the Paris classification for each patient by adhering to present guidelines and then by including microscopic findings.
RESULTS: Macroscopic and combined disease location classifications were discordant in 34 (56.6%), with no statistically significant differences between groups. Interobserver agreement was higher in the combined classification (κ = 0.73, 95% confidence interval 0.65-0.82) as opposed to when classification was limited to macroscopic findings (κ = 0.53, 95% confidence interval 0.40-0.58). When evaluating the proximal upper gastrointestinal tract (Paris L4a), the interobserver agreement was better in macroscopic compared with the combined classification.
CONCLUSIONS: Disease extent classifications differed significantly when comparing isolated macroscopic findings (Paris classification) with the combined scheme that included microscopy. Further studies are needed to determine which scheme provides more accurate representation of disease extent.

Entities:  

Mesh:

Year:  2016        PMID: 26334258      PMCID: PMC5357324          DOI: 10.1097/MPG.0000000000000967

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  16 in total

Review 1.  Classification of inflammatory bowel disease: the old and the new.

Authors:  Severine Vermeire; Gert Van Assche; Paul Rutgeerts
Journal:  Curr Opin Gastroenterol       Date:  2012-07       Impact factor: 3.287

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

3.  Understanding interobserver agreement: the kappa statistic.

Authors:  Anthony J Viera; Joanne M Garrett
Journal:  Fam Med       Date:  2005-05       Impact factor: 1.756

4.  Upper gastrointestinal mucosal disease in pediatric Crohn disease and ulcerative colitis: a blinded, controlled study.

Authors:  J M Tobin; B Sinha; P Ramani; A R Saleh; M S Murphy
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-04       Impact factor: 2.839

5.  The role of esophagogastroduodenoscopy in the initial evaluation of childhood inflammatory bowel disease: a 7-year study.

Authors:  Bisher A Abdullah; Sandeep K Gupta; Joseph M Croffie; Marian D Pfefferkorn; Jean Pappas Molleston; Mark R Corkins; Joseph F Fitzgerald
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-11       Impact factor: 2.839

6.  Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis.

Authors:  F Sharif; M McDermott; M Dillon; B Drumm; M Rowland; C Imrie; S Kelleher; S Harty; B Bourke
Journal:  Am J Gastroenterol       Date:  2002-06       Impact factor: 10.864

7.  Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease.

Authors:  R K Russell; H E Drummond; E R Nimmo; N H Anderson; C L Noble; D C Wilson; P M Gillett; P McGrogan; K Hassan; L T Weaver; W M Bisset; G Mahdi; J Satsangi
Journal:  Gut       Date:  2006-02-09       Impact factor: 23.059

Review 8.  Definition and evaluation of mucosal healing in clinical practice.

Authors:  Silvia Mazzuoli; Francesco W Guglielmi; Elisabetta Antonelli; Marianna Salemme; Gabrio Bassotti; Vincenzo Villanacci
Journal:  Dig Liver Dis       Date:  2013-08-07       Impact factor: 4.088

9.  Recognition of Crohn disease on incidental gastric biopsy in childhood.

Authors:  Judy Mae Pascasio; Susan Hammond; Stephen J Qualman
Journal:  Pediatr Dev Pathol       Date:  2003-03-28

10.  Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis.

Authors:  Dan Turner; Anne M Griffiths
Journal:  Curr Gastroenterol Rep       Date:  2009-06
View more
  2 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

2.  Classification of Paediatric Inflammatory Bowel Disease using Machine Learning.

Authors:  E Mossotto; J J Ashton; T Coelho; R M Beattie; B D MacArthur; S Ennis
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.